世界のエリスロポエチン刺激剤市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Erythropoietin Stimulating Agents Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z2245 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、91ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、エリスロポエチン刺激剤のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（エポエチンアルファ、エポエチンベータ、ダルベポエチンアルファ、その他）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・エリスロポエチン刺激剤の市場動向 ・企業の競争状況、市場シェア ・エリスロポエチン刺激剤の種類別市場規模（エポエチンアルファ、エポエチンベータ、ダルベポエチンアルファ、その他） ・エリスロポエチン刺激剤の用途別市場規模（病院、クリニック、その他） ・エリスロポエチン刺激剤の北米市場規模2016-2027（アメリカ、カナダ） ・エリスロポエチン刺激剤のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・エリスロポエチン刺激剤のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・エリスロポエチン刺激剤の中南米市場規模2016-2027（メキシコ、ブラジル） ・エリスロポエチン刺激剤の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Pfizer、Amgen、BioSidus、Biocon、Celltrion、Roche、Intas Pharmaceuticals、Johnson and Johnson、Teva Pharmaceutical Industries、Thermo Fisher Scientific） ・結論

Erythropoiesis-stimulating agents (ESA) are medications which stimulate the bone marrow to make red blood cells. They are used to treat anemia due to end stage kidney disease, chemotherapy, major surgery, or certain treatments in HIV/AIDS.

Market Analysis and Insights: Global Erythropoietin Stimulating Agents Market
The global Erythropoietin Stimulating Agents market size is projected to reach US$ 6164.5 million by 2026, from US$ 6115.2 million in 2019, at a CAGR of 0.1% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Erythropoietin Stimulating Agents market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Erythropoietin Stimulating Agents market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Erythropoietin Stimulating Agents market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Erythropoietin Stimulating Agents market.

Global Erythropoietin Stimulating Agents Scope and Market Size
Erythropoietin Stimulating Agents market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Erythropoietin Stimulating Agents market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Epoetin Alfa
Epoetin Beta
Darbepoetin Alfa
Others

Segment by Application
Hospitals
Clinics
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Pfizer
Amgen
BioSidus
Biocon
Celltrion
Roche
Intas Pharmaceuticals
Johnson and Johnson
Teva Pharmaceutical Industries

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Erythropoietin Stimulating Agents Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Epoetin Alfa
1.2.3 Epoetin Beta
1.2.4 Darbepoetin Alfa
1.2.5 Others
1.3 Market by Application
1.3.1 Global Erythropoietin Stimulating Agents Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Erythropoietin Stimulating Agents Market Perspective (2016-2027)
2.2 Erythropoietin Stimulating Agents Growth Trends by Regions
2.2.1 Erythropoietin Stimulating Agents Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Erythropoietin Stimulating Agents Historic Market Share by Regions (2016-2021)
2.2.3 Erythropoietin Stimulating Agents Forecasted Market Size by Regions (2022-2027)
2.3 Erythropoietin Stimulating Agents Industry Dynamic
2.3.1 Erythropoietin Stimulating Agents Market Trends
2.3.2 Erythropoietin Stimulating Agents Market Drivers
2.3.3 Erythropoietin Stimulating Agents Market Challenges
2.3.4 Erythropoietin Stimulating Agents Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Erythropoietin Stimulating Agents Players by Revenue
3.1.1 Global Top Erythropoietin Stimulating Agents Players by Revenue (2016-2021)
3.1.2 Global Erythropoietin Stimulating Agents Revenue Market Share by Players (2016-2021)
3.2 Global Erythropoietin Stimulating Agents Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Erythropoietin Stimulating Agents Revenue
3.4 Global Erythropoietin Stimulating Agents Market Concentration Ratio
3.4.1 Global Erythropoietin Stimulating Agents Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Erythropoietin Stimulating Agents Revenue in 2020
3.5 Erythropoietin Stimulating Agents Key Players Head office and Area Served
3.6 Key Players Erythropoietin Stimulating Agents Product Solution and Service
3.7 Date of Enter into Erythropoietin Stimulating Agents Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Erythropoietin Stimulating Agents Breakdown Data by Type
4.1 Global Erythropoietin Stimulating Agents Historic Market Size by Type (2016-2021)
4.2 Global Erythropoietin Stimulating Agents Forecasted Market Size by Type (2022-2027)

5 Erythropoietin Stimulating Agents Breakdown Data by Application
5.1 Global Erythropoietin Stimulating Agents Historic Market Size by Application (2016-2021)
5.2 Global Erythropoietin Stimulating Agents Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Erythropoietin Stimulating Agents Market Size (2016-2027)
6.2 North America Erythropoietin Stimulating Agents Market Size by Type
6.2.1 North America Erythropoietin Stimulating Agents Market Size by Type (2016-2021)
6.2.2 North America Erythropoietin Stimulating Agents Market Size by Type (2022-2027)
6.2.3 North America Erythropoietin Stimulating Agents Market Size by Type (2016-2027)
6.3 North America Erythropoietin Stimulating Agents Market Size by Application
6.3.1 North America Erythropoietin Stimulating Agents Market Size by Application (2016-2021)
6.3.2 North America Erythropoietin Stimulating Agents Market Size by Application (2022-2027)
6.3.3 North America Erythropoietin Stimulating Agents Market Size by Application (2016-2027)
6.4 North America Erythropoietin Stimulating Agents Market Size by Country
6.4.1 North America Erythropoietin Stimulating Agents Market Size by Country (2016-2021)
6.4.2 North America Erythropoietin Stimulating Agents Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Erythropoietin Stimulating Agents Market Size (2016-2027)
7.2 Europe Erythropoietin Stimulating Agents Market Size by Type
7.2.1 Europe Erythropoietin Stimulating Agents Market Size by Type (2016-2021)
7.2.2 Europe Erythropoietin Stimulating Agents Market Size by Type (2022-2027)
7.2.3 Europe Erythropoietin Stimulating Agents Market Size by Type (2016-2027)
7.3 Europe Erythropoietin Stimulating Agents Market Size by Application
7.3.1 Europe Erythropoietin Stimulating Agents Market Size by Application (2016-2021)
7.3.2 Europe Erythropoietin Stimulating Agents Market Size by Application (2022-2027)
7.3.3 Europe Erythropoietin Stimulating Agents Market Size by Application (2016-2027)
7.4 Europe Erythropoietin Stimulating Agents Market Size by Country
7.4.1 Europe Erythropoietin Stimulating Agents Market Size by Country (2016-2021)
7.4.2 Europe Erythropoietin Stimulating Agents Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Erythropoietin Stimulating Agents Market Size (2016-2027)
8.2 Asia-Pacific Erythropoietin Stimulating Agents Market Size by Type
8.2.1 Asia-Pacific Erythropoietin Stimulating Agents Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Erythropoietin Stimulating Agents Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Erythropoietin Stimulating Agents Market Size by Type (2016-2027)
8.3 Asia-Pacific Erythropoietin Stimulating Agents Market Size by Application
8.3.1 Asia-Pacific Erythropoietin Stimulating Agents Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Erythropoietin Stimulating Agents Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Erythropoietin Stimulating Agents Market Size by Application (2016-2027)
8.4 Asia-Pacific Erythropoietin Stimulating Agents Market Size by Region
8.4.1 Asia-Pacific Erythropoietin Stimulating Agents Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Erythropoietin Stimulating Agents Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Erythropoietin Stimulating Agents Market Size (2016-2027)
9.2 Latin America Erythropoietin Stimulating Agents Market Size by Type
9.2.1 Latin America Erythropoietin Stimulating Agents Market Size by Type (2016-2021)
9.2.2 Latin America Erythropoietin Stimulating Agents Market Size by Type (2022-2027)
9.2.3 Latin America Erythropoietin Stimulating Agents Market Size by Type (2016-2027)
9.3 Latin America Erythropoietin Stimulating Agents Market Size by Application
9.3.1 Latin America Erythropoietin Stimulating Agents Market Size by Application (2016-2021)
9.3.2 Latin America Erythropoietin Stimulating Agents Market Size by Application (2022-2027)
9.3.3 Latin America Erythropoietin Stimulating Agents Market Size by Application (2016-2027)
9.4 Latin America Erythropoietin Stimulating Agents Market Size by Country
9.4.1 Latin America Erythropoietin Stimulating Agents Market Size by Country (2016-2021)
9.4.2 Latin America Erythropoietin Stimulating Agents Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Erythropoietin Stimulating Agents Market Size (2016-2027)
10.2 Middle East & Africa Erythropoietin Stimulating Agents Market Size by Type
10.2.1 Middle East & Africa Erythropoietin Stimulating Agents Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Erythropoietin Stimulating Agents Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Erythropoietin Stimulating Agents Market Size by Type (2016-2027)
10.3 Middle East & Africa Erythropoietin Stimulating Agents Market Size by Application
10.3.1 Middle East & Africa Erythropoietin Stimulating Agents Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Erythropoietin Stimulating Agents Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Erythropoietin Stimulating Agents Market Size by Application (2016-2027)
10.4 Middle East & Africa Erythropoietin Stimulating Agents Market Size by Country
10.4.1 Middle East & Africa Erythropoietin Stimulating Agents Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Erythropoietin Stimulating Agents Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Erythropoietin Stimulating Agents Introduction
11.1.4 Pfizer Revenue in Erythropoietin Stimulating Agents Business (2016-2021)
11.1.5 Pfizer Recent Development
11.2 Amgen
11.2.1 Amgen Company Details
11.2.2 Amgen Business Overview
11.2.3 Amgen Erythropoietin Stimulating Agents Introduction
11.2.4 Amgen Revenue in Erythropoietin Stimulating Agents Business (2016-2021)
11.2.5 Amgen Recent Development
11.3 BioSidus
11.3.1 BioSidus Company Details
11.3.2 BioSidus Business Overview
11.3.3 BioSidus Erythropoietin Stimulating Agents Introduction
11.3.4 BioSidus Revenue in Erythropoietin Stimulating Agents Business (2016-2021)
11.3.5 BioSidus Recent Development
11.4 Biocon
11.4.1 Biocon Company Details
11.4.2 Biocon Business Overview
11.4.3 Biocon Erythropoietin Stimulating Agents Introduction
11.4.4 Biocon Revenue in Erythropoietin Stimulating Agents Business (2016-2021)
11.4.5 Biocon Recent Development
11.5 Celltrion
11.5.1 Celltrion Company Details
11.5.2 Celltrion Business Overview
11.5.3 Celltrion Erythropoietin Stimulating Agents Introduction
11.5.4 Celltrion Revenue in Erythropoietin Stimulating Agents Business (2016-2021)
11.5.5 Celltrion Recent Development
11.6 Roche
11.6.1 Roche Company Details
11.6.2 Roche Business Overview
11.6.3 Roche Erythropoietin Stimulating Agents Introduction
11.6.4 Roche Revenue in Erythropoietin Stimulating Agents Business (2016-2021)
11.6.5 Roche Recent Development
11.7 Intas Pharmaceuticals
11.7.1 Intas Pharmaceuticals Company Details
11.7.2 Intas Pharmaceuticals Business Overview
11.7.3 Intas Pharmaceuticals Erythropoietin Stimulating Agents Introduction
11.7.4 Intas Pharmaceuticals Revenue in Erythropoietin Stimulating Agents Business (2016-2021)
11.7.5 Intas Pharmaceuticals Recent Development
11.8 Johnson and Johnson
11.8.1 Johnson and Johnson Company Details
11.8.2 Johnson and Johnson Business Overview
11.8.3 Johnson and Johnson Erythropoietin Stimulating Agents Introduction
11.8.4 Johnson and Johnson Revenue in Erythropoietin Stimulating Agents Business (2016-2021)
11.8.5 Johnson and Johnson Recent Development
11.9 Teva Pharmaceutical Industries
11.9.1 Teva Pharmaceutical Industries Company Details
11.9.2 Teva Pharmaceutical Industries Business Overview
11.9.3 Teva Pharmaceutical Industries Erythropoietin Stimulating Agents Introduction
11.9.4 Teva Pharmaceutical Industries Revenue in Erythropoietin Stimulating Agents Business (2016-2021)
11.9.5 Teva Pharmaceutical Industries Recent Development
11.10 Thermo Fisher Scientific
11.10.1 Thermo Fisher Scientific Company Details
11.10.2 Thermo Fisher Scientific Business Overview
11.10.3 Thermo Fisher Scientific Erythropoietin Stimulating Agents Introduction
11.10.4 Thermo Fisher Scientific Revenue in Erythropoietin Stimulating Agents Business (2016-2021)
11.10.5 Thermo Fisher Scientific Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Erythropoietin Stimulating Agents Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Epoetin Alfa
Table 3. Key Players of Epoetin Beta
Table 4. Key Players of Darbepoetin Alfa
Table 5. Key Players of Others
Table 6. Global Erythropoietin Stimulating Agents Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Erythropoietin Stimulating Agents Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Erythropoietin Stimulating Agents Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Erythropoietin Stimulating Agents Market Share by Regions (2016-2021)
Table 10. Global Erythropoietin Stimulating Agents Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Erythropoietin Stimulating Agents Market Share by Regions (2022-2027)
Table 12. Erythropoietin Stimulating Agents Market Trends
Table 13. Erythropoietin Stimulating Agents Market Drivers
Table 14. Erythropoietin Stimulating Agents Market Challenges
Table 15. Erythropoietin Stimulating Agents Market Restraints
Table 16. Global Erythropoietin Stimulating Agents Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Erythropoietin Stimulating Agents Market Share by Players (2016-2021)
Table 18. Global Top Erythropoietin Stimulating Agents Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Erythropoietin Stimulating Agents as of 2020)
Table 19. Ranking of Global Top Erythropoietin Stimulating Agents Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Erythropoietin Stimulating Agents Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Erythropoietin Stimulating Agents Product Solution and Service
Table 23. Date of Enter into Erythropoietin Stimulating Agents Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Erythropoietin Stimulating Agents Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Erythropoietin Stimulating Agents Revenue Market Share by Type (2016-2021)
Table 27. Global Erythropoietin Stimulating Agents Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Erythropoietin Stimulating Agents Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Erythropoietin Stimulating Agents Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Erythropoietin Stimulating Agents Revenue Market Share by Application (2016-2021)
Table 31. Global Erythropoietin Stimulating Agents Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Erythropoietin Stimulating Agents Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Erythropoietin Stimulating Agents Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Erythropoietin Stimulating Agents Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Erythropoietin Stimulating Agents Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Erythropoietin Stimulating Agents Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Erythropoietin Stimulating Agents Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Erythropoietin Stimulating Agents Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Erythropoietin Stimulating Agents Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Erythropoietin Stimulating Agents Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Erythropoietin Stimulating Agents Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Erythropoietin Stimulating Agents Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Erythropoietin Stimulating Agents Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Erythropoietin Stimulating Agents Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Erythropoietin Stimulating Agents Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Erythropoietin Stimulating Agents Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Erythropoietin Stimulating Agents Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Erythropoietin Stimulating Agents Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Erythropoietin Stimulating Agents Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Erythropoietin Stimulating Agents Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Erythropoietin Stimulating Agents Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Erythropoietin Stimulating Agents Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Erythropoietin Stimulating Agents Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Erythropoietin Stimulating Agents Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Erythropoietin Stimulating Agents Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Erythropoietin Stimulating Agents Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Erythropoietin Stimulating Agents Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Erythropoietin Stimulating Agents Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Erythropoietin Stimulating Agents Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Erythropoietin Stimulating Agents Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Erythropoietin Stimulating Agents Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Erythropoietin Stimulating Agents Market Size by Country (2022-2027) & (US$ Million)
Table 63. Pfizer Company Details
Table 64. Pfizer Business Overview
Table 65. Pfizer Erythropoietin Stimulating Agents Product
Table 66. Pfizer Revenue in Erythropoietin Stimulating Agents Business (2016-2021) & (US$ Million)
Table 67. Pfizer Recent Development
Table 68. Amgen Company Details
Table 69. Amgen Business Overview
Table 70. Amgen Erythropoietin Stimulating Agents Product
Table 71. Amgen Revenue in Erythropoietin Stimulating Agents Business (2016-2021) & (US$ Million)
Table 72. Amgen Recent Development
Table 73. BioSidus Company Details
Table 74. BioSidus Business Overview
Table 75. BioSidus Erythropoietin Stimulating Agents Product
Table 76. BioSidus Revenue in Erythropoietin Stimulating Agents Business (2016-2021) & (US$ Million)
Table 77. BioSidus Recent Development
Table 78. Biocon Company Details
Table 79. Biocon Business Overview
Table 80. Biocon Erythropoietin Stimulating Agents Product
Table 81. Biocon Revenue in Erythropoietin Stimulating Agents Business (2016-2021) & (US$ Million)
Table 82. Biocon Recent Development
Table 83. Celltrion Company Details
Table 84. Celltrion Business Overview
Table 85. Celltrion Erythropoietin Stimulating Agents Product
Table 86. Celltrion Revenue in Erythropoietin Stimulating Agents Business (2016-2021) & (US$ Million)
Table 87. Celltrion Recent Development
Table 88. Roche Company Details
Table 89. Roche Business Overview
Table 90. Roche Erythropoietin Stimulating Agents Product
Table 91. Roche Revenue in Erythropoietin Stimulating Agents Business (2016-2021) & (US$ Million)
Table 92. Roche Recent Development
Table 93. Intas Pharmaceuticals Company Details
Table 94. Intas Pharmaceuticals Business Overview
Table 95. Intas Pharmaceuticals Erythropoietin Stimulating Agents Product
Table 96. Intas Pharmaceuticals Revenue in Erythropoietin Stimulating Agents Business (2016-2021) & (US$ Million)
Table 97. Intas Pharmaceuticals Recent Development
Table 98. Johnson and Johnson Company Details
Table 99. Johnson and Johnson Business Overview
Table 100. Johnson and Johnson Revenue in Erythropoietin Stimulating Agents Business (2016-2021) & (US$ Million)
Table 101. Johnson and Johnson Recent Development
Table 102. Teva Pharmaceutical Industries Company Details
Table 103. Teva Pharmaceutical Industries Business Overview
Table 104. Teva Pharmaceutical Industries Erythropoietin Stimulating Agents Product
Table 105. Teva Pharmaceutical Industries Revenue in Erythropoietin Stimulating Agents Business (2016-2021) & (US$ Million)
Table 106. Teva Pharmaceutical Industries Recent Development
Table 107. Thermo Fisher Scientific Company Details
Table 108. Thermo Fisher Scientific Business Overview
Table 109. Thermo Fisher Scientific Erythropoietin Stimulating Agents Product
Table 110. Thermo Fisher Scientific Revenue in Erythropoietin Stimulating Agents Business (2016-2021) & (US$ Million)
Table 111. Thermo Fisher Scientific Recent Development
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Erythropoietin Stimulating Agents Market Share by Type: 2020 VS 2027
Figure 2. Epoetin Alfa Features
Figure 3. Epoetin Beta Features
Figure 4. Darbepoetin Alfa Features
Figure 5. Others Features
Figure 6. Global Erythropoietin Stimulating Agents Market Share by Application: 2020 VS 2027
Figure 7. Hospitals Case Studies
Figure 8. Clinics Case Studies
Figure 9. Others Case Studies
Figure 10. Erythropoietin Stimulating Agents Report Years Considered
Figure 11. Global Erythropoietin Stimulating Agents Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Erythropoietin Stimulating Agents Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Erythropoietin Stimulating Agents Market Share by Regions: 2020 VS 2027
Figure 14. Global Erythropoietin Stimulating Agents Market Share by Regions (2022-2027)
Figure 15. Global Erythropoietin Stimulating Agents Market Share by Players in 2020
Figure 16. Global Top Erythropoietin Stimulating Agents Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Erythropoietin Stimulating Agents as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Erythropoietin Stimulating Agents Revenue in 2020
Figure 18. Global Erythropoietin Stimulating Agents Revenue Market Share by Type (2016-2021)
Figure 19. Global Erythropoietin Stimulating Agents Revenue Market Share by Type (2022-2027)
Figure 20. North America Erythropoietin Stimulating Agents Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Erythropoietin Stimulating Agents Market Share by Type (2016-2027)
Figure 22. North America Erythropoietin Stimulating Agents Market Share by Application (2016-2027)
Figure 23. North America Erythropoietin Stimulating Agents Market Share by Country (2016-2027)
Figure 24. United States Erythropoietin Stimulating Agents Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Erythropoietin Stimulating Agents Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Erythropoietin Stimulating Agents Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Erythropoietin Stimulating Agents Market Share by Type (2016-2027)
Figure 28. Europe Erythropoietin Stimulating Agents Market Share by Application (2016-2027)
Figure 29. Europe Erythropoietin Stimulating Agents Market Share by Country (2016-2027)
Figure 30. Germany Erythropoietin Stimulating Agents Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Erythropoietin Stimulating Agents Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Erythropoietin Stimulating Agents Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Erythropoietin Stimulating Agents Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Erythropoietin Stimulating Agents Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Erythropoietin Stimulating Agents Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Erythropoietin Stimulating Agents Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Erythropoietin Stimulating Agents Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Erythropoietin Stimulating Agents Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Erythropoietin Stimulating Agents Market Share by Region (2016-2027)
Figure 40. China Erythropoietin Stimulating Agents Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Erythropoietin Stimulating Agents Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Erythropoietin Stimulating Agents Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Erythropoietin Stimulating Agents Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Erythropoietin Stimulating Agents Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Erythropoietin Stimulating Agents Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Erythropoietin Stimulating Agents Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Erythropoietin Stimulating Agents Market Share by Type (2016-2027)
Figure 48. Latin America Erythropoietin Stimulating Agents Market Share by Application (2016-2027)
Figure 49. Latin America Erythropoietin Stimulating Agents Market Share by Country (2016-2027)
Figure 50. Mexico Erythropoietin Stimulating Agents Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Erythropoietin Stimulating Agents Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Erythropoietin Stimulating Agents Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Erythropoietin Stimulating Agents Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Erythropoietin Stimulating Agents Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Erythropoietin Stimulating Agents Market Share by Country (2016-2027)
Figure 56. Turkey Erythropoietin Stimulating Agents Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Erythropoietin Stimulating Agents Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Erythropoietin Stimulating Agents Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Pfizer Revenue Growth Rate in Erythropoietin Stimulating Agents Business (2016-2021)
Figure 60. Amgen Revenue Growth Rate in Erythropoietin Stimulating Agents Business (2016-2021)
Figure 61. BioSidus Revenue Growth Rate in Erythropoietin Stimulating Agents Business (2016-2021)
Figure 62. Biocon Revenue Growth Rate in Erythropoietin Stimulating Agents Business (2016-2021)
Figure 63. Celltrion Revenue Growth Rate in Erythropoietin Stimulating Agents Business (2016-2021)
Figure 64. Roche Revenue Growth Rate in Erythropoietin Stimulating Agents Business (2016-2021)
Figure 65. Intas Pharmaceuticals Revenue Growth Rate in Erythropoietin Stimulating Agents Business (2016-2021)
Figure 66. Johnson and Johnson Revenue Growth Rate in Erythropoietin Stimulating Agents Business (2016-2021)
Figure 67. Teva Pharmaceutical Industries Revenue Growth Rate in Erythropoietin Stimulating Agents Business (2016-2021)
Figure 68. Thermo Fisher Scientific Revenue Growth Rate in Erythropoietin Stimulating Agents Business (2016-2021)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed

---